Skip to main content
OpenTrials
Completed

NCT Number: NCT02223676

Clinical Pharmacists in the Emergency Department

The purpose of this study is to investigate the effect of implementing clinical pharmacists in the Emergency Department Team at Randers Regional Hospital. The clinical pharmacists conduct medication history, make medical interaction screenings, -reconciliations and -reviews on unscheduled patients admitted to the Emergency Department during daytime.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Randers Regional Hospital

Randers, Region Midt, 8900, Denmark

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • unscheduled patients admitted to the Emergency Department at Randers Regional Hospital at weekdays during daytime (9 am to 16.15 pm)
  • 4 or more drugs prescribed

Exclusion criteria

  • patients triage red
  • patients who cannot give informed consent
  • terminal patients
  • patients admitted to detoxification
  • patients refered to the acute outpatient department
  • patients remaining in the Emergency Department overnight

Treatment and study plan

Clinical pharmacists conduct medication history

Procedure

pharmacists conduct medication history before the physician interviews the patient and does not spend time on conducting medical history

Primary outcomes

  1. Emergency Department Length of stay

    Time frame: From arrival to the Emergency Department to either admission or discharge, which in average will be 6 hours.

Secondary outcomes

  1. Time from patient arrival to the treatment schedule is ready

    Time frame: From arrival to the Emergency Department to either admission or discharge, which in average will be 6 hours.

  2. Patient safety

    Time frame: From arrival to the Emergency Department to either admission or discharge, which in average will be 6 hours.

    Number of recommended changes in drugs or dosage per patient. The changes are rated according to a PCNE-classification for drug-related problems.

Other outcomes

  1. The impact of the intervention in the Emergency Department on the existing medication review by clinical pharmacist at the acute ward

    Time frame: 1-3 days after admission to Emergency Department when the secondary medication review takes place

    We estimate whether the intervention is time-saving (by recording and comparing time spent for secondary/excisting medication review at the acute ward between patients allocated to the intervention and control group, respectively) and reduce the workload of the clinicians (number and kind of interventions at secondary medication review in the two groups)

  2. The impact of the intervention in the Emergency Department on the dispensing of medicine (done by nurses)

    Time frame: During actual admission to the Emergency Department and the period after inclusion of patients

    time used and the possibility of substitutions

Sponsors and collaborators

Lead sponsor

Randers Regional Hospital

Other

Collaborators

  • Aarhus University Hospital

Registry information

Official study title

Is Length of Stay in the Emergency Department Reduced When Clinical Pharmacists Conduct Medication History? - a Cluster Randomized Study

Important dates

Study start
2013
Primary completion
2014
Study completion
2014
First posted
Aug 22, 2014
Registry last updated
May 21, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.